Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

19:08 IST NSE
New Order WinRailTel Corporation of India Ltd RAILTEL

RailTel Corporation of India Bags ₹145.5 Cr Order

RailTel Corporation of India Ltd. secured a major order worth ₹145.47 Crore from Eastern Coalfields Limited. The contract involves providing MPLS-VPN, Internet Leased Line, and managed bandwidth services. The project is scheduled for execution by May 2031, providing long-term revenue visibility.

Value
₹145.5 Cr
Execution
02-MAY-31
19:06 IST NSE
Debt & BorrowingRossell India Ltd ROSSELLIND

Rossell India Debt & Borrowing: ₹47.47 Cr

Rossell India Limited confirmed it does not qualify as a 'Large Corporate' for FY 2026-2027 under SEBI norms. The company reported outstanding long-term borrowings of ₹47.47 Crore as of March 31, 2026, significantly below the ₹1,000 Crore threshold. This regulatory disclosure clarifies the company's borrowing status and compliance with debt-raising frameworks.

Value
₹47.47 Cr
19:06 IST BSE
Earnings CallBank of Maharashtra MAHABANK

Bank of Maharashtra Earnings Call: Key Takeaways

Bank of Maharashtra Q4 FY26 earnings transcript. Bank met or exceeded 18-19 guidance parameters, focusing on RAM growth and maintaining a high CASA ratio above 50% while improving asset quality.

19:00 IST NSE
Promoter ReclassificationEID Parry (India) Ltd EIDPARRY

EID Parry (India) Promoter Reclassification

E.I.D. - Parry (India) Limited received approval from NSE and BSE for the declassification of Algavista Greentech Private Limited from its promoter group. The reclassification follows the company's applications under SEBI Listing Regulations. This administrative change formally removes AGPL from the promoter category as of April 27, 2026.

18:58 IST NSE
AcquisitionSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Acquisition Worth ₹37,649 Cr

Sun Pharmaceutical's US subsidiary will acquire 100% of Organon & Co. for ₹37,649 Crore ($3.99B equity value) in an all-cash merger. The deal, valued at $11.75B enterprise value, strengthens Sun's global portfolio in women's health and biosimilars. Completion is expected in early 2027, subject to regulatory and shareholder approvals.

Value
₹37,649 Cr
Execution
Early 2027